PROSTAGLANDIN SYNTHESIS AND ACTION IN THE PRIMATE CORPUS LUTEUM
灵长类黄体中前列腺素的合成和作用
基本信息
- 批准号:8173187
- 负责人:
- 金额:$ 9.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAgonistAnimalsComputer Retrieval of Information on Scientific Projects DatabaseDataDevelopmentDinoprostoneFundingGrantInstitutionLuteal PhaseLuteolysisPTGS2 genePhysiologyPlayPreparationPrimatesProstaglandin E ReceptorProstaglandinsProtocols documentationResearchResearch PersonnelResourcesRoleScreening procedureSignal TransductionSourceStructureTestingUnited States National Institutes of Healthcorpus luteumcyclooxygenase 2inhibitor/antagonistprimate developmentreceptorresearch studyrestoration
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The long-term objective of this research is to define the mechanisms occurring within the primate corpus luteum (CL) that are critical for its development and regression. Evidence obtained from nonprimate species indicates that prostaglandins (PGs) regulate luteal structure-function, but their role in primate luteal physiology have not been defined. Preliminary data demonstrated that the expression of PGE2 synthesis (prostaglandin-endoperoxide synthase 2, PTGS2; microsomal PGE2 synthase-1, PTGES) and signaling (PGE2 receptor 3, PTGER3) components peak in the primate CL through the period of its development. Moreover, expression of the PGE2 synthesizing and signaling components significantly decreased preceding the period of functional regression of the CL, which also coincided with increasing levels of PGF2a receptor (PTGFR) expression. Thus, experiments will be performed to test the hypothesis that PGE2 actions are critical for primate luteal development, while PGF2a serves as a critical initiator of luteolysis. Studies are proposed that will assess the role PGE2 signaling plays in the development of the primate CL and evaluate whether PGF2a signaling is required for the demise of the CL at the end of the luteal phase. Protocols blocking intraluteal PG synthesis via a PTGS2 selective inhibitor will determine their role in CL development. The ablation of PG synthesis in the developing CL will be combined with the restoration of PTGER3 signaling through the use of a selective PTGER3 agonist. Progress to date includes the initial screening and vehicle treatment of animals in preparation for administration of a selective PTGS2 inhibitor and a PGF2a antagonist.
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jon D Hennebold其他文献
Jon D Hennebold的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jon D Hennebold', 18)}}的其他基金
Rhesus Macaque Somatic Cell Gene Editing Resource
恒河猴体细胞基因编辑资源
- 批准号:
10457930 - 财政年份:2018
- 资助金额:
$ 9.51万 - 项目类别:
Rhesus Macaque Somatic Cell Gene Editing Resource
恒河猴体细胞基因编辑资源
- 批准号:
10222805 - 财政年份:2018
- 资助金额:
$ 9.51万 - 项目类别:
Rhesus Macaque Somatic Cell Gene Editing Resource
恒河猴体细胞基因编辑资源
- 批准号:
9978950 - 财政年份:2018
- 资助金额:
$ 9.51万 - 项目类别:
Rhesus Macaque Somatic Cell Gene Editing Resource
恒河猴体细胞基因编辑资源
- 批准号:
9788549 - 财政年份:2018
- 资助金额:
$ 9.51万 - 项目类别:
Hyperandrogenemia, Diet and Female Reproductive Health
高雄激素血症、饮食和女性生殖健康
- 批准号:
9908126 - 财政年份:2013
- 资助金额:
$ 9.51万 - 项目类别:
Leukemia Inhibitory Factor As a Mediator of Primate Ovulation & Oocyte Maturation
白血病抑制因子作为灵长类动物排卵的调节剂
- 批准号:
8554777 - 财政年份:2012
- 资助金额:
$ 9.51万 - 项目类别:
Leukemia Inhibitory Factor As a Mediator of Primate Ovulation & Oocyte Maturation
白血病抑制因子作为灵长类动物排卵的调节剂
- 批准号:
8443168 - 财政年份:2012
- 资助金额:
$ 9.51万 - 项目类别:
PROSTAGLANDIN SYNTHESIS AND ACTION IN THE PRIMATE CORPUS LUTEUM
灵长类黄体中前列腺素的合成和作用
- 批准号:
8357742 - 财政年份:2011
- 资助金额:
$ 9.51万 - 项目类别:
IDENTIFICATION AND CHARACTERIZATION OF KEY PROTEASES NECESSARY FOR OVULATION
排卵所需的关键蛋白酶的鉴定和表征
- 批准号:
8357891 - 财政年份:2011
- 资助金额:
$ 9.51万 - 项目类别:
NOVEL CONTRACEPTIVES: CONTROL OF FOLLICULAR MATURATION AND RUPTURE
新型避孕药:控制卵泡成熟和破裂
- 批准号:
8357771 - 财政年份:2011
- 资助金额:
$ 9.51万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 9.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 9.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 9.51万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 9.51万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 9.51万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 9.51万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 9.51万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 9.51万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 9.51万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 9.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)